How a Tumor Evolves: Drivers, Passengers, and Genomic Instability

Evolution inside the body

Here is the unifying idea that ties this whole track together: a tumor is a tiny population of cells evolving by natural selection, right inside the body. Every cell division can introduce new somatic mutations. Most do nothing. But occasionally a mutation gives a cell a slight edge — it divides a little faster, or ignores a stop signal. That cell leaves more descendants. Over many generations of cells, the fastest-growing lineages dominate.

This is exactly Darwin's logic — variation, selection, inheritance — but the “individuals” are cells and the “environment” is your tissue. The same forces you would study in population genetics are at work in a single tumor. Seeing cancer as evolution explains its most frustrating features: why it adapts, why it varies from cell to cell, and why it can grow back resistant after treatment.

Drivers and passengers

A cancer cell carries thousands of mutations, but they are not equal. A driver mutation is one that actually gives the cell a growth advantage — it activates an oncogene or disables a tumor-suppressor gene. Drivers are the changes selection acts on; they steer the tumor. A passenger mutation is one that just happened to be present in a cell when it expanded, carried along for the ride without helping the cancer grow.

Genomic instability: stepping on the mutation gas

Evolution needs variation to act on, and one of the most dangerous early events in cancer is a jump in the rate of new mutations. When repair genes (like the BRCA and Lynch genes from guide 4) or chromosome-maintenance systems fail, the genome becomes genomically unstable — errors are made and not corrected, and whole chromosomes can be miscounted or rearranged. The mutation supply line floods open.

Genomic instability acts as an accelerant. The more mutations a cell makes, the higher the odds that some will be new drivers. So an early hit to the DNA repair machinery can speed everything that follows. This is one reason p53 matters so much: losing the guardian both removes a brake and raises the mutation rate, a double blow.

How accumulated mutations build a tumor (clonal evolution)

Start: 1 normal cell, two good copies of every cancer gene.

Step 1  Driver hit #1: a proto-oncogene is activated.
        -> this cell divides slightly faster. Its lineage (clone) expands.

Step 2  Within that growing clone, a repair gene is lost.
        -> GENOMIC INSTABILITY: mutation rate jumps.
        -> many new mutations appear, most are passengers.

Step 3  Driver hit #2: a tumor suppressor loses BOTH copies
        (e.g. one point mutation + loss of heterozygosity).
        -> a brake fails; this sub-clone grows faster still and dominates.

Step 4  Driver hit #3: p53 is lost.
        -> damaged cells no longer pause or self-destruct;
        -> instability worsens, more drivers accumulate.

Result  A cell carrying SEVERAL drivers (+ thousands of passengers)
        now grows without control = cancer.

Reading the logic:
  - Each step is selected because it gives a growth edge (natural selection).
  - Drivers steer; passengers ride along.
  - Instability supplies the variation that selection feeds on.
  - No single mutation did it -- the ACCUMULATION did.

A worked walk-through of clonal evolution: how a sequence of selected driver hits, sped along by genomic instability, accumulates until a cell grows without control.

This whole sequence is called clonal evolution. A tumor is not one uniform thing but a branching family tree of related clones, each carrying its founder's drivers plus its own new mutations. That internal diversity is why cancer is so hard to defeat: a treatment may clear most clones, yet one resistant lineage can survive and regrow. Understanding cancer as accumulated, selected genetic change is the foundation for every modern attempt to outsmart it.